Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Journal of Clinical Pharmacology
|
April 29, 2014
Population pharmacometric analyses of eribulin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes
Oneeb Majid, Anubha Gupta, Larisa Reyderman, et al.
Current Medical Research and Opinion
|
September 24, 2004
Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers
Larisa Reyderman, Teddy Kosoglou, Tanya Boutros, et al.
Current Medical Research and Opinion
|
August 9, 2005
The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe
Larisa Reyderman, Teddy Kosoglou, David L Cutler, et al.
Journal of Clinical Pharmacology
|
December 16, 2022
Exposure-Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia
Bojan Lalovic, Ishani Savant Landry, Margaret Moline, et al.
Epilepsy & Behavior : E&B
|
May 10, 2021
Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians
Barry E Gidal, Jim Ferry, Larisa Reyderman, et al.
Clinical Pharmacokinetics
|
August 10, 2002
Lack of clinically relevant interaction between desloratadine and erythromycin
Christopher Banfield, Thomas Hunt, Larisa Reyderman, et al.
Clinical Pharmacology in Drug Development
|
May 21, 2022
Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study
Ziad Hussein, Oneeb Majid, Peter Boyd, et al.
Pharmacology Research & Perspectives
|
March 10, 2021
Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Pharmacology Research & Perspectives
|
November 2, 2020
Effect of gastric acid-reducing agents on the pharmacokinetics and efficacy of lemborexant
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Pharmacology Research & Perspectives
|
April 6, 2021
Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant
Satish Dayal, Jagadeesh Aluri, Nancy Hall, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Journal of Clinical Pharmacology
|
April 29, 2014
Population pharmacometric analyses of eribulin in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes
Oneeb Majid, Anubha Gupta, Larisa Reyderman, et al.
Current Medical Research and Opinion
|
September 24, 2004
Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers
Larisa Reyderman, Teddy Kosoglou, Tanya Boutros, et al.
Current Medical Research and Opinion
|
August 9, 2005
The effect of fluvastatin on the pharmacokinetics and pharmacodynamics of ezetimibe
Larisa Reyderman, Teddy Kosoglou, David L Cutler, et al.
Journal of Clinical Pharmacology
|
December 16, 2022
Exposure-Response Analyses of Polysomnography and Subjective Sleep Efficacy End Points From the Phase 3 Trials of Lemborexant, a Dual Orexin Receptor Antagonist for the Treatment of Insomnia
Bojan Lalovic, Ishani Savant Landry, Margaret Moline, et al.
Epilepsy & Behavior : E&B
|
May 10, 2021
Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians
Barry E Gidal, Jim Ferry, Larisa Reyderman, et al.
Clinical Pharmacokinetics
|
August 10, 2002
Lack of clinically relevant interaction between desloratadine and erythromycin
Christopher Banfield, Thomas Hunt, Larisa Reyderman, et al.
Clinical Pharmacology in Drug Development
|
May 21, 2022
Intravenous Perampanel as an Interchangeable Alternative to Oral Perampanel: A Randomized, Crossover, Phase I Pharmacokinetic and Safety Study
Ziad Hussein, Oneeb Majid, Peter Boyd, et al.
Pharmacology Research & Perspectives
|
March 10, 2021
Effect of severe renal impairment on pharmacokinetics, safety, and tolerability of lemborexant
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Pharmacology Research & Perspectives
|
November 2, 2020
Effect of gastric acid-reducing agents on the pharmacokinetics and efficacy of lemborexant
Ishani Landry, Jagadeesh Aluri, Nancy Hall, et al.
Pharmacology Research & Perspectives
|
April 6, 2021
Effect of hepatic impairment on pharmacokinetics, safety, and tolerability of lemborexant
Satish Dayal, Jagadeesh Aluri, Nancy Hall, et al.
Page
of 7